Composition for inhibiting liver function deterioration, containing citrus peel extract or narirutin as active ingredient, and method for extracting narirutin from citrus peel

US9724361B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9724361-B2
Application numberUS-201414229352-A
CountryUS
Kind codeB2
Filing dateMar 28, 2014
Priority dateSep 30, 2011
Publication dateAug 8, 2017
Grant dateAug 8, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a pharmaceutical composition for treating liver diseases, containing a narirutin extract of citrus peel extract or narirutin as an active ingredient. The extract or narirutin decreases cholesterol levels and fat levels in liver tissue, and thus can be utilized as a composition or food for preventing and treating liver diseases. In addition, the present invention relates to a method for extracting narirutin from citrus peel, and a method for preparing citrus fermented milk using the same.

First claim

Opening claim text (preview).

The invention claimed is: 1. A pharmaceutical composition for treating or preventing alcoholic liver diseases, the composition comprising a citrus peel extract containing narirutin as an active ingredient, flavored fermented milk, and at least one vehicle, wherein the narirutin comprises 4% to 75% content in the citrus peel extract, and wherein the citrus peel extract containing narirutin is between 0.5-1% of the composition. 2. The composition of claim 1 , wherein the composition is an orally administrable composition. 3. The composition of claim 1 , wherein the composition is used in the form of a concentrate, a tablet, a hard capsule, or a soft capsule. 4. A food composition for improving alcoholic liver diseases, the composition comprising a citrus peel extract containing narirutin as an active ingredient, flavored fermented milk, and at least one vehicle, wherein the narirutin comprises 4% to 75% content in the citrus peel extract, and wherein the citrus peel extract containing narirutin is between 0.5-1% of the composition. 5. A method for treating or preventing alcoholic liver diseases, comprising: administering a pharmaceutical composition including an effective amount of a citrus peel extract containing narirutin as an active ingredient, flavored fermented milk, and at least one vehicle to a subject in need thereof, wherein the narirutin comprises 4% to 75% content in the citrus peel extract, and wherein the citrus peel extract containing narirutin is between 0.5-1% of the composition.

Assignees

Inventors

Classifications

  • A61K36/752Primary

    Citrus, e.g. lime, orange or lemon · CPC title

  • Extraction of the material · CPC title

  • from natural products · CPC title

  • Benzo[b]pyran-4-ones · CPC title

  • having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9724361B2 cover?
The present invention relates to a pharmaceutical composition for treating liver diseases, containing a narirutin extract of citrus peel extract or narirutin as an active ingredient. The extract or narirutin decreases cholesterol levels and fat levels in liver tissue, and thus can be utilized as a composition or food for preventing and treating liver diseases. In addition, the present invention…
Who is the assignee on this patent?
Korea Food Res Inst
What technology area does this patent fall under?
Primary CPC classification A61K36/752. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).